Medical Ventures Corp. (MEV) Begins FDA Submission Process For Metricath Gemini  
8/27/2007 8:25:26 AM

RICHMOND, BRITISH COLUMBIA--(Marketwire - Aug. 27, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV - News) has submitted to the U.S. Food and Drug Administration the first of three modules of a pre-market approval (PMA) application for coronary use of the Metricath GeminiĀ® catheter. Submitting the PMA application module initiates the process to obtain FDA approval for the medical device.